搜索筛选:
搜索耗时0.1059秒,为你在为你在102,285,761篇论文里面共找到 13 篇相符的论文内容
类      型:
[期刊论文] 作者:Yu-Yun Shao,Chih-Hung Hsu,Ann-Lii Cheng,, 来源:World Journal of Gastroenterology 年份:2015
Sorafenib is the current standard treatment for advanced hepatocellular carcinoma(HCC),but its efficacy is modest with low response rates and short response dur...
[期刊论文] 作者:Shih-Hung Yang,Chiun Hsu,Ann-Lii Cheng,Sung-Hsin Kuo,, 来源:World Journal of Hematology 年份:2014
Over the past decade, the administration of anti-CD20 monoclonal antibodies such as rituximab has demonstrated various degrees of effectiveness and has improved...
[期刊论文] 作者:Yen-Shen Lu,Huang-Chun Lien,Pei-Yen Yeh,Kun-Huei Yeh,Sung-Hsin Kuo,Ann-Lii Cheng,, 来源:World Journal of Gastroenterology 年份:2005
AIM: To determine how glucocorticoids (GCs) may affect the growth and chemosensitivity of common carcinoma cells. METHODS: The effect of dexamethasone (DEX) on...
[会议论文] 作者:Shukui Qin,Ann-Lii Cheng,Ho Yeong Lim,Lianzhe Xu,Cindy Li,Friedhelm Bladt, 来源:第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份:2014
[会议论文] 作者:Shukui Qin,Ann-Lii Cheng,Ho Yeong Lim,Lianzhe Xu,Cindy Li,Friedhelm Bladt, 来源:第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份:2014
Objective: Advanced hepatocellular carcinoma (HCC) is a leading cause of cancer death, particularly in Asia where ~80% of HCC incidences occur.Although sorafenib is the recommended treatment, it is no...
[期刊论文] 作者:Ching-hung LIN,Huang-chun LIEN,Yen-shen LU,Sung-hsin KUO,Ann-lii CHENG,King-jen CHANG,Chiun-sheng HUANG, 来源:Journal of Zhejiang University-Science B(Biomedicine & Biote 年份:2010
Objective:To compare the prognostic prediction between dichotomized and fractionated evaluations of hormone receptor expressions. Methods: Patients with stages...
[期刊论文] 作者:Yen-Shen Lu,Huang-Chun Lien,Pei-Yen Yeh,Kun-Huei Yeh,Min-Liang Kuo,Sung-Hsin Kuo,Ann-Lii Cheng, 来源:世界胃肠病学杂志(英文版) 年份:2005
AIM: To determine how glucocorticoids (GCs) may affect the growth and chemosensitivity of common carcinoma cells.METHODS: The effect of dexamethasone (DEX) on g...
[会议论文] 作者:Shukui Qin,Ho yeong Lim,Baek-yeol Ryoo,Cindy Li,Huiling Xiong,Christian Ihling,Ann-lii Cheng, 来源:第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份:2015
Objective: The overall prognosis of advanced hepatocellular cancer (HCC) remains poor, with c-Met abnormalities associated with a particularly poor prognosis.The highly selective c-Met inhibitor tepot...
[会议论文] 作者:Shukui Qin,Ho yeong Lim,Baek-yeol Ryoo,Cindy Li,Huiling Xiong,Andreas Johne,Ann-lii Cheng, 来源:第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份:2015
Background: HCC, a poor-prognosis disease for which the only approved drug is sorafenib, has a high unmet need.Factors associated with tumor aggressiveness in advanced HCC include c-Met amplification/...
[期刊论文] 作者:Li-Tzong Chen,Shin-Lian Doong,Kun-Huei Yeh,Tsui-Lien Mao,Hui-Chen Hsu,Hsiu-Po Wang,Jaw-Town Lin,Ann-Lii Cheng, 来源:World Journal of Gastroenterology 年份:2005
AIM: A high percentage of early-stage high-grade gastric mucosa-associated lymphoid tissue (MALT) lymphomas remain Helicobacter(H pylori)-dependent.. However, u...
[期刊论文] 作者:Shih-Hung Yang,Ting-Chun Kuo,Hsu Wu,Jhe-Cyuan Guo,Chiun Hsu,Chih-Hung Hsu,Yu-Wen Tien,Kun-Huei Yeh,Ann-Lii Cheng, 来源:World Journal of Gastroenterology 年份:2016
Pancreatic cancer is highly lethal. Current research that combines radiation with targeted therapy may dramatically improve prognosis. Cancerous cells are chara...
[期刊论文] 作者:Shin-Lian Doong,Kun-Huei Yeh,Ming-Shiang Wu,Tsui-Lien Mao,Hui-Chen Hsu,Hsiu-Po Wang,Jaw-Town Lin,Ann-Lii Cheng, 来源:世界胃肠病学杂志(英文版) 年份:2005
AIM: A high percentage of early-stage high-grade gastric mucosa-associated lymphoid tissue (MALT) lymphomas remain Helicobacter pylori(H pylori)-dependent. Howe...
[期刊论文] 作者:Chi-Chung Wen,Chao A.Hsiung,Ih-Jen Su,Ann-Lii Cheng,Ming-Chih Chang,Chao-Jung Tsao,Woei-Yao Kao,Wu-Ching, 来源:World Journal of Gastroenterology 年份:2005
AIM:To investigate the long-term consequences of chemotherapy-related HBV reactivation in patients with lymphoma. METHODS:This study was based on the database o...
相关搜索: